CANSLIM Stock Screener – 2026-09-04 (113 Stocks)

Software remains the dominant force in today’s selection, with Software – Application contributing 29 names and Software – Infrastructure adding 19 more. Together these two groups account for 48 of the 113 stocks that passed the CAN SLIM stock screener, representing over 40 percent of the total list. Oil & Gas Refining & Marketing is a distant third with 8 names, indicating a clear technology-heavy tilt in the current market environment.

Nine stocks were confirmed by two or more screening criteria, marking them as the strongest signals in today’s universe: SNOW, BRZE, CRM, DAVE, DELL, ECO, ETON, PLTR, and TEAM. This multi-screen overlap suggests these names exhibit broader fundamental and technical strength than the single-criterion entries. The list includes a mix of large-cap software leaders and smaller emerging names, reflecting diverse opportunities among the CANSLIM stocks currently under review.

Among the three-screen confirmed names, SNOW stands out with an advancing price trend and a falling wedge pattern that is still developing. The base is relatively immature, with a depth of 9.3 percent and a formation period of just 3.0 weeks, placing its pivot at $337.38. This early-stage structure suggests the pattern has not yet fully resolved, and the stock remains in the process of building its foundation rather than completing a breakout.

For educational purposes only — not investment advice.


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading